Printer Friendly

TELECONCEPTS REPORTS RESULTS

 TELECONCEPTS REPORTS RESULTS
 NEWINGTON, Conn., Nov. 19 /PRNewswire/ -- TeleConcepts Corporation


(AMEX: TCC) announced that net sales for the third quarter of 1991 were $2,162,000 versus $2,925,000 for the same period of 1990. This decline is consistent with the general decline of retail sales in consumer electronics.
 Net sales for the first nine months of 1991 were $5,216,000 versus $7,102,000 for the same period in 1990. Backlog at Sept. 30, 1991, was $1,651,000 versus $1,402,000 at Sept. 30, 1990.
 Costs of goods sold for the third quarter of 1991 was $1,744,000 versus $2,268,000 for the same period of 1990. The percentage of net sales for these periods for cost of goods sold was 80.6 percent and 77.5 percent, respectively. This increase in the cost of goods sold percentage was due to a reduction in the amount of overhead allocated to inventory as a result of lower purchasing levels and additional air freight costs for transport of telephones from the Far East.
 Selling, general and administrative expenses were down from $543,000 in the third quarter of 1990 to $473,000 in the third quarter of 1991 due primarily to reductions in commissions and advertising allowances which are generally tied to net sales.
 Inventories have decreased from $3,380,000 as of Dec. 30, 1990, to $1,759,000 as of Sept. 30, 1991, as a result of a change in inventory purchasing procedures.
 Short-term borrowing has been reduced from $1,090,000 at year end 1990 to $309,000 at Sept. 30, 1991, due primarily to the company's ability to sell its inventory and reduce its purchases of new product.
 Interest declined from $92,000 in the third quarter of 1990 to $60,000 in the same period of 1991 due primarily to reduced borrowing.
 Net loss for the third quarter of 1991 was $126,000 versus a net profit of $10,000 for the third quarter of 1990. This variation was due almost entirely to the reduced sales volume. Net loss for the first nine months of 1991 was $708,000 versus $191,000 for the same period of 1990.
 TELECONCEPTS CORPORATION
 Financial Highlights
 Periods ended Three Months Nine Months
 Sept. 30 1991 1990 1991 1990
 (Unaudited)
 Net sales $2,162,000 $2,925,000 $5,216,000 $7,102,000
 Net income (loss) (126,000) 10,331 (708,000) (191,000)
 Net loss per share $(.02) -- $(.11) $(.03)
 Avg. shrs. outstdg. 6,639,422 6,639,422 6,639,422 6,639,422
 9/30/91 12/31/90
 (Unaudited) (Audited)
 Total assets $5,249,000 $6,640,000
 Working capital 2,535,000 3,266,000
 Total liabilities 2,832,000 3,514,000
 Stockholders' equity 2,417,000 3,125,000
 Estimated federal net
 operating loss carryover 17,316,000 16,608,000
 -0- 11/19/91
 /CONTACT: William D. Putt of TeleConcepts, 203-666-5666/
 (TCC) CO: TeleConcepts Corporation ST: Connecticut IN: TLS SU: ERN JT-CK -- NY031 -- 4912 11/19/91 11:26 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 19, 1991
Words:514
Previous Article:CONSUMERS POWER COMPANY RECEIVES NATIONAL ENVIRONMENTAL RECOGNITION
Next Article:AT&T ANNOUNCES LONG-DISTANCE SERVICE AT PALM BEACH INTERNATIONAL AIRPORT
Topics:


Related Articles
TELECONCEPTS ISSUES STATEMENT ON STOCK TRANSACTION
TELECONCEPTS REPORTS STOCK SALE BY CONTROLLING SHAREHOLDERS; NAMES MONTLE AND CULOTTA TO BOARD
TELECONCEPTS CORPORATION ANNOUNCES RESULTS
TELECONCEPTS SETS NEW DATE FOR SPECIAL MEETING TO APPROVE MERGER
TELECONCEPTS SAYS AIDS TEST MAY IDENTIFY NEW HIV STRAIN
TELECONCEPTS SETS NEW DATE FOR SPECIAL MEETING TO APPROVE MERGER WITH THERMASCAN - PRIVATE PLACEMENT FULLY COMMITTED
THE JOURNAL OF CLINICAL MICROBIOLOGY REPORTS THAT A NEW FDA-APPROVED AIDS TEST WILL IMPROVE SPECIFICITY OF HIV CONFIRMATORY TESTING
TELECONCEPTS STOCKHOLDERS APPROVE MERGER WITH THERMASCAN; TERMS MAY CHANGE
TELECONCEPTS ELECTS FREDERICK R. ADLER TO ITS BOARD
TELECONCEPTS COMPLETES ACQUISITION OF RIGHTS TO MARKET FDA-APPROVED CONFIRMATION AND SCREENING TEST FOR AIDS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters